In Vitro Flow Rate Dependency of Delivered Dose and Fine Particle Dose of Salmeterol/Fluticasone Propionate Easyhaler and Seretide Diskus with Patient Flow Rates Collected in a Randomized Controlled Trial

Background: The Easyhaler(®) device-metered dry powder inhaler containing Salmeterol and Fluticasone propionate (S/F) has been developed for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD). We report two studies which evaluated the in vitro flow rate dependence...

Descripción completa

Detalles Bibliográficos
Autores principales: Jõgi, Rain, Lähelmä, Satu, Vahteristo, Mikko, Happonen, Anita, Haikarainen, Jussi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477585/
https://www.ncbi.nlm.nih.gov/pubmed/30300557
http://dx.doi.org/10.1089/jamp.2018.1463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477585/
https://www.ncbi.nlm.nih.gov/pubmed/30300557
http://dx.doi.org/10.1089/jamp.2018.1463

Ejemplares similares